Pharmaceutical manufacturing
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2024 | GLENMARK PHARMACEUTICALS USA |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination (No Activity) |
— | — | |
| 2024 | GLENMARK PHARMACEUTICALS USA |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | — | |
| 2023 | GLENMARK PHARMACEUTICALS USA |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | — | |
| 2023 | GLENMARK PHARMACEUTICALS USA |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | — | |
| 2023 | GLENMARK PHARMACEUTICALS USA |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | — | |
| 2023 | GLENMARK PHARMACEUTICALS USA |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | — | |
| 2023 | GLENMARK PHARMACEUTICALS USA |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | — | |
| 2022 | GLENMARK PHARMACEUTICALS USA |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | — | |
| 2022 | GLENMARK PHARMACEUTICALS USA |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
— | $115,000 | |
| 2022 | GLENMARK PHARMACEUTICALS USA |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $136,000 |
| Client | Filings | Total Income |
|---|---|---|
| GLENMARK PHARMACEUTICALS USA | 33 | — |
| Name | Disclosed Prior Position |
|---|---|
| GRANT ERDEL | Senator Christopher Bond - Legislative Correspondent Representative Jo Ann Emerson - Administration Assistant Represen… |